Serum HE4 and CA125 combined to predict and monitor recurrence of type II endometrial carcinoma

Serum HE4 and CA125 combined to predict and monitor recurrence of type II endometrial carcinoma

Abstract There is no recognized serum biomarker to predict the recurrence of endometrial carcinoma (EC). We aimed to explore serum human epididymis protein 4 (HE4) and cancer antigen 125 (CA125) as the biomarkers to predict and monitor recurrence of type II EC. 191 patients diagnosed with type II EC...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Quan Quan, Qianqian Liao, Wanchun Yin, Shuwei Zhou, Sainan Gong, Xiaoling Mu
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
Medicine
R
Science
Q
Acceso en línea:https://doaj.org/article/689f3bf0919449cda19cfc08390a1656
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Ejemplares similares